Advertisement
U.S. Markets closed

Britannia Life Sciences Inc. (BLAB.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
0.0450-0.0250 (-35.71%)
At close: 03:56PM EST

Britannia Life Sciences Inc.

120 Adelaide Street West
Suite 2400
Toronto, ON M5H 1T1
Canada
416 433 9259
https://britannia.life

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

NameTitlePayExercisedYear Born
Mr. Peter James Shippen C.A.I.A., C.P.A., CFACEO & Director215.4kN/A1981
Ms. Sarah Zilik C.A., CPASecretary & CFO132kN/A1980
Mr. Mark Bowes-CavanaghChief Technical Officer172kN/A1973
Mr. Boris NovanskyPresidentN/AN/AN/A
Micah SimmonsVice President of Corporate DevelopmentN/AN/AN/A
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Britannia Life Sciences Inc. engages in the provision of product testing, safety assessment, and compliance services primarily to the cosmetics, consumer packaged and household goods, and nutraceutical industries in the United Kingdom and internationally. The company is headquartered in Toronto, Canada.

Corporate Governance

Britannia Life Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.